
Carefully screen couples
Before pregnancy, meet both parents to review medical histories and discuss the donation process.
See how screening, preparation and documented checks stay connected to the treatment proposed for you—from the donating family to your personal care record.


Caring families. Careful screening. Ongoing follow-up. A well-documented collection.

Before pregnancy, meet both parents to review medical histories and discuss the donation process.

Once pregnant, review pregnancy health, screening results and donation consent.

Review relevant prenatal findings, diet, nutrition and any changes that could affect eligibility.

Link the collected cord with the screening, pregnancy, laboratory and patient records.
We have one of the largest pre-Covid era medical stem cell banks in the world and the ONLY one in Colombia. All cells have been preserved cryogenically for decades of research and use.
Each treatment batch originates from one screened cord donor. Source records follow the material through cryopreservation, preparation and your treatment. Cells from different donors are never pooled.

We're unique in that our lab owns this cord-derived cell bank. Its original cord donations were collected before COVID-19 and before COVID-19 vaccines were available.
The bank is cryopreserved under monitored conditions. The laboratory expects its existing bank to support at least another decade of planned production.
Each documented step answers a practical question about the preparation proposed for you.
Know the donated material’s documented source and screening history.
Keep the collection identifier connected to its handling records.
Identify the cells used for the proposed preparation.
Record the culture stages and checks as cells grow.
Keep preservation conditions and material records connected.
Cells are prepared for use under the handling protocol. Cell-count and viability results form part of the release review.
Cell identity, viability and required safety-test records are reviewed against the laboratory’s release criteria.
Record the preparation used in your care and connect it to your plan.
Before clinical use, the laboratory verifies cell quantity, assesses the percentage of living cells and reviews the required quality-test results. A batch-linked certificate connects the preparation to those records.
Automated analysis measures and records the number of viable, live cells in the batch prepared for you. As an ISO-certified lab, the process has an exceptional 94% viability standard. The FDA minimum standard is 70%.
94%MinimumThe aim is an appropriate living-cell dose for your condition and treatment route. Our medical team draws on relevant research and clinical experience, considering cell quality and delivery alongside quantity.


Your written plan identifies the preparation, clinical procedure, appointments and follow-up—with clear inclusions and one full price. Before you travel, you’ll know what’s proposed and who’s responsible for each step.

The same quality standards support every plan; stay tiers change practical arrangements, not clinical quality.